Vident Investment Advisory’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,197	Closed	-$83.4K	–	1213
2023 Q1	$83.4K	Buy	+12,197	New	+$83.4K	﹤0.01%	1177